Table 1. Details and characteristics of included studies.
Study | Year | Design | n* | Population characteristics (age, yrs) |
---|---|---|---|---|
Chu et al.(33) | 2020 | Cross-sectional | 28 | Reproductive-aged women with PCOS (Mean 28.14; SD 3.72) (n=14) Reproductive-aged women without PCOS (controls) (Mean 29.43; SD 3.31) (n=14) |
Flores et al. (23) | 2012 | Cross-sectional | 51 | Healthy men (Mean 38.8; SD 12.27) (n=25) Healthy women (Mean 40.2; SD 12.4) (n=26; premenopausal n=19; postmenopausal n=7) |
Fuhrman et al. (24) | 2014 | Cross-sectional | 60 | Healthy postmenopausal women (Mean 60.3; SD 3.2) (n=60) |
Goedert et al. (21) | 2015 | Casecontrol | 96 | Postmenopausal breast cancer patients (Mean 62.17; SD 6.5) (n=48) Postmenopausal normal mammography patients (Mean 61.85; SD 3.6) (n=48) |
Goedert et al. (22) | 2018 | Cross-sectional | 96 | Postmenopausal breast cancer patients (Mean 62.17; SD 6.5) (n=48) Postmenopausal normal mammography patients (Mean 61.85; SD 3.6) (n=48) |
He et al.(26) | 2020 | Cross-sectional | 106 | Postmenopausal women with osteopenia (Mean 57.42; SD 5.06)(n=33) Postmenopausal women with osteoporosis (mean 59.69; SD 5.51) (n=42) Postmenopausal women with normal BMD (mean 57.35; SD 3.98) (n=31) |
Insenser et al. (30) | 2018 | Cross-sectional | 46 | Women with PCOS (Mean 26.7; SD 6.4) (n=15) Non-hyperandrogenic control women (Mean 27.3; SD 5.3) (n=16) Healthy control men (Mean 23.4; SD 3.3) (n=15) |
Liang et al. (29) | 2020 | Cross-sectional | 27 | Obese women with PCOS (Mean 27.1; SD 3.5)(n=8) Normal-weight PCOS women (Mean 25.7; SD 3.5)(n=10) Healthy normal-weight women (Mean 27.9; SD 3.6) (n=9) |
Liu et al.(27) | 2017 | Cross-sectional | 48 | Premenopausal women with PCOS (Mean 32.5; SD 5.7) (n=33) Premenopausal women without PCOS (Mean 27.9; SD 5.7) (controls) (n=15) |
Shin et al. (25) | 2019 | Cross-sectional | 57 | Men (Mean 37.45; SD 1.91) (n=31) Women (Mean 46.15; SD 2.26) (n=26) |
Torres et al. (31) | 2018 | Cross-sectional | 163 | Healthy premenopausal women (Mean 29.4; SD 4.9) (n=48) Premenopausal women with PCOM (Mean 29.8; SD 5.3) (n=42) Premenopausal women with PCOS (Mean 27.4; SD 4.9) (n=73) |
Zengul et al. (32) | 2020 | Cross-sectional | 29 | Postmenopausal women with breast cancer (Mean 62.3; SD 8.5) (n=29) |
Zhou et al. (28) | 2020 | Cross-sectional | 101 | Women with PCOS (Mean 23.6; SD 2.96)(n=60) Healthy women (control group) (Mean 26.5; SD 3.99) (n=41) |
n= Total number of participants.